8-K/AThe WireRoutine
Shareholder Vote
Filed Sep 18, 2025 · 9mo ago · Accession 0001193125-25-207401
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Stoke Therapeutics, Inc.
- Ticker
- STOK
- CIK
- 1623526
- Form type
- 8-K/A
- Filing date
- Sep 18, 2025
- Report date
- Jun 3, 2025
- Document
- d798098d8ka.htm
- Size
- 137 KB